Drug combination for the treatment of neurodegenerative disorders such as Huntington`s disease and several spinocerebellar ataxias caused by abnormal CAG repeat expansions, comprises Ketanov and Itraconazole
	SHUKLA S; KUMAR A
	2024-12-18
专利权人	INDIAN INST TECHNOLOGY INDORE (INTE-Non-standard)
申请日期	2024-12-18
专利号	IN202421100308-A
成果简介	NOVELTY - Drug combination comprises Ketanov and Itraconazole. USE - Drug combination for the treatment of neurodegenerative disorders such as Huntington`s disease and several spinocerebellar ataxias caused by abnormal CAG repeat expansions (all claimed). No biological data given. ADVANTAGE - The composition has improved synergistic efficacy, high selectivity and specificity, enhanced biological activity, and enhanced safety profile.
IPC 分类号	A61K-031/496 ; A61K-047/38 ; A61K-009/00
国家	印度
专业领域	医药卫生
语种	英语
成果类型	专利
文献类型	科技成果
条目标识符	http://119.78.100.226:8889/handle/3KE4DYBR/13973
专题	中国科学院新疆生态与地理研究所
作者单位	INDIAN INST TECHNOLOGY INDORE (INTE-Non-standard)
推荐引用方式 GB/T 7714	SHUKLA S,KUMAR A. Drug combination for the treatment of neurodegenerative disorders such as Huntington`s disease and several spinocerebellar ataxias caused by abnormal CAG repeat expansions, comprises Ketanov and Itraconazole. IN202421100308-A[P]. 2024.

条目包含的文件
条目无相关文件。

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。